Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | BMY | GSK | ||
| Company | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 434.31 | 58.67 | 51.14 | ||
| High | 439.98 | 59.21 | 51.27 | ||
| Low | 427.64 | 58.11 | 50.68 | ||
| Latest | 430.44 | 58.54 | 50.78 | ||
| Change | -3.87 | +0.23 | -0.27 | ||
| % Change | -0.89% | +0.39% | -0.53% | ||
| Volume | 1,756,472 | 8,537,256 | 2,874,480 | ||
| 20-Day Average Volume | 1,168,342 | 10,133,876 | 4,194,125 | ||
| Previous Close | 434.31 | 58.31 | 51.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 432.89 | 57.50 | 51.57 | ||
| 20-Day Raw Stochastic | 40.55% | 58.23% | 24.03% | ||
| 20-Day Relative Strength | 45.33 | 52.31 | 42.25 | ||
| Weighted Alpha | -1.32 | +26.08 | +26.68 | ||
| Today's Opinion | 56% Sell | 56% Buy | 24% Sell | ||
| Previous Opinion | 40% Sell | 40% Buy | 8% Sell | ||
| Last Month's Opinion | 24% Sell | 64% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.03% since 05/13/26 | +3.80% since 05/13/26 | +0.06% since 05/13/26 | ||
| Low | 427.64 on 05/20/26 | 56.10 on 05/14/26 | 49.38 on 05/15/26 | ||
| High | 456.68 on 05/14/26 | 59.21 on 05/20/26 | 51.31 on 05/14/26 | ||
| 1-Month | |||||
| %Chg | -2.03% since 04/20/26 | -1.01% since 04/20/26 | -11.04% since 04/20/26 | ||
| Low | 412.27 on 05/05/26 | 55.40 on 05/11/26 | 49.38 on 05/15/26 | ||
| High | 456.68 on 05/14/26 | 60.78 on 04/30/26 | 56.51 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | -9.78% since 02/20/26 | -3.50% since 02/20/26 | -14.28% since 02/20/26 | ||
| Low | 412.27 on 05/05/26 | 55.40 on 05/11/26 | 49.38 on 05/15/26 | ||
| High | 507.92 on 03/10/26 | 62.89 on 03/02/26 | 59.94 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +1.88% since 11/20/25 | +27.42% since 11/20/25 | +10.65% since 11/20/25 | ||
| Low | 412.27 on 05/05/26 | 45.52 on 11/21/25 | 46.47 on 11/21/25 | ||
| High | 507.92 on 03/10/26 | 62.89 on 03/02/26 | 61.69 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 110,230,048 | 119,073,168 | 103,590,560 | ||
| Shares Outstanding, K | 253,805 | 2,042,071 | 2,029,198 | ||
| Annual Sales | 12,001,300,000 | 48,194,000,000 | 43,077,970,000 | ||
| Annual Net Income | 3,953,200,000 | 7,054,000,000 | 7,537,690,000 | ||
| Last Quarter Sales | 2,986,900,000 | 11,489,000,000 | 10,280,080,000 | ||
| Last Quarter Net Income | 1,031,400,000 | 2,677,000,000 | 2,340,610,000 | ||
| 60-Month Beta | 0.30 | 0.26 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 4.47 on 05/04/26 | 1.58 on 04/30/26 | 1.24 on 04/29/26 | ||
| Earnings Date | 08/03/26 | 07/30/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | 0.630 on 04/02/26 | 0.454 on 05/15/26 | ||
| Next Ex-Dividends Date | N/A | 04/02/26 | 05/15/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 25.96 | 9.66 | 10.86 | ||